Skip to search.
 TSX Up 0.74% TSX Ventures Up 0.24%

Merck & Co., Inc. (MRK)

-NYSE
60.06 Down 0.22(0.36%) 4:01PM EST
|After Hours : 60.09 Up 0.03 (0.05%) 4:43PM EST - Nasdaq Real Time Price
Prev Close:60.28
Open:59.70
Bid:59.51 x 1000
Ask:60.10 x 1000
1y Target Est:68.00
Beta:0.842316
Next Earnings Date: 2-Feb-17MRK Earnings announcement
Day's Range:58.62 - 60.06
52wk Range:47.97 - 65.46
Volume:14,040,523
Avg Vol (3m):10,717,400
Market Cap:165.59B
P/E (ttm):30.67
EPS (ttm):1.96
Div & Yield:1.88 (3.08%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
MRKDown 0.36%165.59B
GSKDown 0.37%89.48B
PFEDown 1.17%189.27B
1 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.16
Ex-Dividend Date:13-Dec-16

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infec... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback